BRAP
Basic information
Region (hg38): 12:111642146-111685956
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BRAP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 25 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 0 | 5 |
Variants in BRAP
This is a list of pathogenic ClinVar variants found in the BRAP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-111644212-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
12-111644218-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
12-111644221-C-A | not specified | Uncertain significance (Dec 14, 2023) | ||
12-111644248-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
12-111644252-C-G | not specified | Uncertain significance (Dec 13, 2023) | ||
12-111644281-A-G | not specified | Uncertain significance (Feb 16, 2023) | ||
12-111644438-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
12-111644444-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
12-111644515-T-C | not specified | Uncertain significance (Sep 25, 2024) | ||
12-111644522-C-T | not specified | Uncertain significance (Nov 26, 2024) | ||
12-111644536-G-C | not specified | Uncertain significance (Feb 17, 2024) | ||
12-111650001-C-T | Benign (May 08, 2018) | |||
12-111655618-C-T | not specified | Uncertain significance (Nov 18, 2023) | ||
12-111658779-C-T | not specified | Uncertain significance (Nov 25, 2024) | ||
12-111658780-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
12-111659253-C-T | Benign (Dec 13, 2017) | |||
12-111659295-G-A | Benign (Jun 22, 2018) | |||
12-111660625-T-G | not specified | Uncertain significance (Jun 22, 2021) | ||
12-111660637-A-G | not specified | Uncertain significance (Feb 27, 2023) | ||
12-111660644-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
12-111665684-T-G | not specified | Uncertain significance (Feb 24, 2022) | ||
12-111665708-T-C | not specified | Uncertain significance (Nov 06, 2024) | ||
12-111665785-G-A | Benign (May 08, 2018) | |||
12-111672686-C-T | not specified | Uncertain significance (Sep 12, 2023) | ||
12-111679205-A-G | Benign (May 08, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BRAP | protein_coding | protein_coding | ENST00000419234 | 12 | 43841 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000375 | 1.00 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.89 | 246 | 344 | 0.714 | 0.0000196 | 3916 |
Missense in Polyphen | 65 | 125.42 | 0.51826 | 1390 | ||
Synonymous | 0.134 | 126 | 128 | 0.985 | 0.00000772 | 1076 |
Loss of Function | 3.05 | 15 | 34.3 | 0.437 | 0.00000199 | 384 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000302 | 0.000302 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000116 | 0.000114 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000133 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Negatively regulates MAP kinase activation by limiting the formation of Raf/MEK complexes probably by inactivation of the KSR1 scaffold protein. Also acts as a Ras responsive E3 ubiquitin ligase that, on activation of Ras, is modified by auto- polyubiquitination resulting in the release of inhibition of Raf/MEK complex formation. May also act as a cytoplasmic retention protein with a role in regulating nuclear transport. {ECO:0000269|PubMed:14724641, ECO:0000303|PubMed:10777491}.;
- Pathway
- Ras signaling pathway - Homo sapiens (human);Ras Signaling;RAF activation;Disease;Signal Transduction;Negative regulation of MAPK pathway;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Diseases of signal transduction
(Consensus)
Recessive Scores
- pRec
- 0.339
Intolerance Scores
- loftool
- 0.745
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.56
Haploinsufficiency Scores
- pHI
- 0.540
- hipred
- Y
- hipred_score
- 0.693
- ghis
- 0.579
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.921
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Brap
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype;
Gene ontology
- Biological process
- MAPK cascade;Ras protein signal transduction;negative regulation of signal transduction;protein ubiquitination
- Cellular component
- ubiquitin ligase complex;cytoplasm;cytosol;nuclear membrane
- Molecular function
- nucleic acid binding;ubiquitin-protein transferase activity;protein binding;nuclear localization sequence binding;zinc ion binding;identical protein binding;ubiquitin protein ligase activity